Back to Journals » Vascular Health and Risk Management » Volume 6

Optimal management of familial hypercholesterolemia: treatment and management strategies

Authors Nemati MH, Astaneh

Published 3 December 2010 Volume 2010:6 Pages 1079—1088

DOI https://doi.org/10.2147/VHRM.S8283

Review by Single-blind

Peer reviewer comments 3


Mohammad Hassan Nemati1, Behrooz Astaneh2
1Cardiac Surgery Department, Faghihi Hospital, 2 Vice Chancellor for Research Department, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract: Familial hypercholesterolemia is an autosomally dominant disorder caused by various mutations in low-density lipoprotein receptor genes. This will lead to elevated levels of total and low-density lipoprotein cholesterol, which may in turn lead to premature coronary atherosclerosis and cardiac-related death. The symptoms are more severe in the homozygous type of the disease. Different options for the treatment of affected patients are now available. Diet therapy, pharmacologic therapy, lipid apheresis, and liver transplantation are among the various treatments. We clinically review the treatment and management strategies for the disease in order to shed light on the optimal management of familial hypercholesterolemia.

Keywords: familial hypercholesterolemia, homozygote, heterozygote, Iran

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]